Avalon GloboCare (ALBT) Institutional Ownership $5.42 +0.52 (+10.61%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$5.48 +0.06 (+1.11%) As of 02/21/2025 07:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Avalon GloboCare (NASDAQ:ALBT)CurrentInstitutional OwnershipPercentage1.42%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$161.18K Get ALBT Insider Trade Alerts Want to know when executives and insiders are buying or selling Avalon GloboCare stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ALBT Institutional Buying and Selling by Quarter Avalon GloboCare Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/11/2025 Virtu Financial LLC10,842$35K0.0%-82.0%0.995% 5/1/2023 Virtu Financial LLC20,515$41K0.0%N/A0.202% 11/22/2022 Continental Investors Services Inc.57,600$32K0.0%N/A0.058% 2/10/2022 GM Advisory Group Inc.100,000$82K0.0%N/A0.116% 11/16/2021Telemetry Investments L.L.C.75,000$67K0.1%N/A0.088% 11/9/2021BlackRock Inc.88,149$78K0.0%-19.3%0.103% 9/17/2021 Virtu Financial LLC37,555$37K0.0%N/A0.044% 8/17/2021 Boothbay Fund Management LLC41,659$41K0.0%N/A0.049% 8/13/2021 Renaissance Technologies LLC54,905$54K0.0%-89.2%0.065% 8/13/2021 Northern Trust Corp47,277$46K0.0%-80.5%0.056% 8/13/2021 Geode Capital Management LLC145,258$142K0.0%-45.9%0.172% 8/13/2021 Vanguard Group Inc.580,014$570K0.0%-9.4%0.687% 8/12/2021Ergoteles LLC59,800$59K0.0%N/A0.071% 5/21/2021 Citadel Advisors LLC26,686$29K0.0%N/A0.032% 5/18/2021 Citadel Advisors LLC26,686$29K0.0%N/A0.032% 5/13/2021 Renaissance Technologies LLC509,200$545K0.0%+628.8%0.603% 5/7/2021BlackRock Inc.1,097,743$1.18M0.0%+5.8%1.301% 2/19/2021 JPMorgan Chase & Co.56,386$63K0.0%+316.4%0.069% 2/10/2021 Renaissance Technologies LLC69,872$78K0.0%N/A0.086% 2/5/2021BlackRock Inc.1,037,626$1.16M0.0%+7.4%1.275% (Data available from 1/1/2016 forward) ALBT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ALBT shares? During the previous two years, the following institutional investors and hedge funds held shares of Avalon GloboCare shares: Virtu Financial LLC ($35K).Learn more on ALBT's institutional investors. What percentage of Avalon GloboCare stock is owned by institutional investors? 1.42% of Avalon GloboCare stock is owned by institutional investors. Learn more on ALBT's institutional investor holdings. Which institutional investors have been buying Avalon GloboCare stock? The following institutional investors have purchased Avalon GloboCare stock in the last 24 months: Virtu Financial LLC ($20.52K). How much institutional buying is happening at Avalon GloboCare? Institutional investors have bought a total of 20,515 shares in the last 24 months. This purchase volume represents approximately $609.30K in transactions. Which Avalon GloboCare major shareholders have been selling company stock? The following institutional investors have sold Avalon GloboCare stock in the last 24 months: Virtu Financial LLC ($49.44K). How much institutional selling is happening at Avalon GloboCare? Institutional investors have sold a total of 49,443 shares in the last 24 months. This volume of shares sold represents approximately $161.18K in transactions. Related Companies NeuroSense Therapeutics Institutional Ownership Biomerica Institutional Ownership Eagle Pharmaceuticals Institutional Ownership HCW Biologics Institutional Ownership Cingulate Institutional Ownership CervoMed Institutional Ownership Phio Pharmaceuticals Institutional Ownership Minerva Neurosciences Institutional Ownership Trinity Biotech Institutional Ownership Cellectar Biosciences Institutional Ownership This page (NASDAQ:ALBT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredA strange twist 500 miles from WashingtonEnergy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalon GloboCare Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalon GloboCare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
